Markus Puhlmann
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 6
- Immunology top 10%
- Immunotherapy and Immune Responses 4
- Genetics top 5%
- Virus-based gene therapy research 8
- Biotechnology top 5%
- Virology top 10%
-
- Angiogenesis and VEGF in Cancer 5
-
- Renal cell carcinoma treatment 4
-
- Bladder and Urothelial Cancer Treatments 4
-
- Animal Virus Infections Studies 3
-
- Blood Coagulation and Thrombosis Mechanisms 3
- Co-authors
- H. Richard AlexanderMichael GnantDavid L. BartlettSteven K. LibuttiNancy M. CarrollEwa M. TurnerDavid M. WeinreichCharles K. Brown
- Cited by
- OncologyImmunologyGenetics
- Journals
- Journal of Clinical Oncology (10 papers)Annals of Oncology (4 papers)International Journal of Cancer (2 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Markus Puhlmann
38 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 104
- Oncology 537
- Immunology 403
- Genetics 464
- Biotechnology 143
- Virology 73
Countries citing papers authored by Markus Puhlmann
This map shows the geographic impact of Markus Puhlmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Puhlmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Puhlmann more than expected).
Fields of papers citing papers by Markus Puhlmann
This network shows the impact of papers produced by Markus Puhlmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Puhlmann. The network helps show where Markus Puhlmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Markus Puhlmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2017 | 5 | |
| 4 | 2017 | 6 | |
| 5 | 2016 | 2 | |
| 6 | 2012 | 87 | |
| 7 | 2008 | 3 | |
| 8 | 2007 | 49 | |
| 9 | 2005 | 100 | |
| 10 | 2004 | 6 | |
| 11 | Effect of interleukin 1 receptor antagonist gene transduction on human melanoma xenografts in nude mice. | 2003 | 42 |
| 12 | 2002 | 149 | |
| 13 | 2002 | 146 | |
| 14 | 2000 | 128 | |
| 15 | A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver. | 2000 | 115 |
| 16 | 1999 | 2 | |
| 17 | 1999 | 33 | |
| 18 | 1999 | 51 | |
| 19 | 1999 | 78 | |
| 20 | [Diagnostic problems in acute appendicitis and indications for laparoscopic appendectomy]. | 1996 | 1 |
About Markus Puhlmann
Markus Puhlmann is a scholar working on Structural Biology, Virology, Immunology and Allergy, Hematology and Reproductive Medicine, having authored 38 papers that have together received 1.6k indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Cancer Immunotherapy and Biomarkers (6 papers), Angiogenesis and VEGF in Cancer (5 papers), Renal cell carcinoma treatment (4 papers), Immunotherapy and Immune Responses (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Animal Virus Infections Studies (3 papers) and Blood Coagulation and Thrombosis Mechanisms (3 papers). The work is most often cited by research in Oncology (537 citations), Immunology (403 citations), Genetics (464 citations), Biotechnology (143 citations) and Virology (73 citations). Markus Puhlmann has collaborated with scholars based in United States, Germany and France. Frequent co-authors include H. Richard Alexander, Michael Gnant, David L. Bartlett, Steven K. Libutti, Nancy M. Carroll, Ewa M. Turner, David M. Weinreich, Charles K. Brown, Dina M. Elaraj and Stephen M. Hewitt. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, International Journal of Cancer, Human Gene Therapy and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.